Interestingly, tumor xenografts were almost non-existent at day 30 after implantation suggesting that silencing KCNQ1OT1 using pSEB61 retroviral vector may be a promising option for colon cancer therapy. Here, KCNQ1OT1 is linked to neoplasm.